Growth financing Lirio recently secured 58.9M in funding across multiple rounds, signaling strong investor confidence and potential for scale. This presents an opportunity to engage on enterprise-grade partnerships and expanded deployments across healthcare payers, providers, and life sciences customers.

Life Sciences expansion The company launched Precision Nudging for Life Sciences and announced adoption at 865 Fest, highlighting a clear market entry into pharma and biotech patient engagement. Target life sciences brands, patient support programs, and caregiver communications with behaviorally informed messaging.

Healthcare integrations Existing tech stack includes Cerner and Oracle with integration into Microsoft ecosystem. There is a path to accelerate deployments by aligning with electronic health record (EHR) ecosystems, health IT platforms, and Microsoft-based health data workflows.

Regulatory trust Certifications such as HITRUST CSF, SOC 2 Type II, and NIST positioning reduce risk for enterprise customers. Use these credentials in security-first pitches to healthcare systems, insurers, and life sciences organizations formalizing vendor diligence.

Awarded innovation Recognition for best in innovation and applied AI supports credibility with risk-averse customers. Leverage the Inc. Best in Business accolades to approach large healthcare networks, health plans, and pharmaceutical companies seeking advanced AI-enabled patient engagement solutions.